Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Infertility Drugs Market 2018, Forecast to 2023

  • receipt Report ID : 139201
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 111
  • list Pharmaceuticals and Healthcare

In humans, infertility is the inability to become pregnant or carry a pregnancy to full term. There are many causes of infertility, including some that medical intervention can treat.

Scope of the Report:

This report focuses on the Infertility Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The five major types of ovulation drug therapy are Clomid (Serophene, clomiphene citrate), Femara or letrozole and other aromatase inhibitors, injectable gonadotropins and injectable FSH hormone products, the GnRH pump and Bromocriptine.

The worldwide market for Infertility Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.

Market Segment by Manufacturers, this report covers

Bayer

Ferring

Merck

Novartis

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Clomid

Femara or letrozole

Injectable gonadotropins and injectable FSH hormone products

The GnRH pump

Bromocriptine

Market Segment by Applications, can be divided into

Male

Female

There are 15 Chapters to deeply display the global Infertility Drugs market.

Chapter 1, to describe Infertility Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Infertility Drugs, with sales, revenue, and price of Infertility Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Infertility Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Infertility Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Infertility Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Infertility Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Clomid

1.2.2 Femara or letrozole

1.2.3 Injectable gonadotropins and injectable FSH hormone products

1.2.4 The GnRH pump

1.2.5 Bromocriptine

1.3 Market Analysis by Applications

1.3.1 Male

1.3.2 Female

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Bayer

2.1.1 Business Overview

2.1.1.1 Bayer Description

2.1.1.2 Bayer Headquarter, Main Business and Finance Overview

2.1.2 Bayer Infertility Drugs Product Introduction

2.1.2.1 Infertility Drugs Production Bases, Sales Regions and Major Competitors

2.1.2.2 Infertility Drugs Product Information

2.1.3 Bayer Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.3.1 Bayer Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.1.3.2 Global Bayer Infertility Drugs Market Share in 2017

2.2 Ferring

2.2.1 Business Overview

2.2.1.1 Ferring Description

2.2.1.2 Ferring Headquarter, Main Business and Finance Overview

2.2.2 Ferring Infertility Drugs Product Introduction

2.2.2.1 Infertility Drugs Production Bases, Sales Regions and Major Competitors

2.2.2.2 Infertility Drugs Product Information

2.2.3 Ferring Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.3.1 Ferring Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2.3.2 Global Ferring Infertility Drugs Market Share in 2017

2.3 Merck

2.3.1 Business Overview

2.3.1.1 Merck Description

2.3.1.2 Merck Headquarter, Main Business and Finance Overview

2.3.2 Merck Infertility Drugs Product Introduction

2.3.2.1 Infertility Drugs Production Bases, Sales Regions and Major Competitors

2.3.2.2 Infertility Drugs Product Information

2.3.3 Merck Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.3.1 Merck Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3.3.2 Global Merck Infertility Drugs Market Share in 2017

2.4 Novartis

2.4.1 Business Overview

2.4.1.1 Novartis Description

2.4.1.2 Novartis Headquarter, Main Business and Finance Overview

2.4.2 Novartis Infertility Drugs Product Introduction

2.4.2.1 Infertility Drugs Production Bases, Sales Regions and Major Competitors

2.4.2.2 Infertility Drugs Product Information

2.4.3 Novartis Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.3.1 Novartis Infertility Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4.3.2 Global Novartis Infertility Drugs Market Share in 2017

3 Global Infertility Drugs Market Competition, by Manufacturer

3.1 Global Infertility Drugs Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Infertility Drugs Revenue and Market Share by Manufacturer (2016-2017)

3.3 Global Infertility Drugs Price by Manufacturer (2016-2017)

3.4 Market Concentration Rate

3.4.1 Top 3 Infertility Drugs Manufacturer Market Share in 2017

3.4.2 Top 5 Infertility Drugs Manufacturer Market Share in 2017

3.5 Market Competition Trend

4 Global Infertility Drugs Market Analysis by Regions

4.1 Global Infertility Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Infertility Drugs Sales by Regions (2013-2018)

4.1.2 Global Infertility Drugs Revenue by Regions (2013-2018)

4.2 North America Infertility Drugs Sales, Revenue and Growth Rate (2013-2018)

4.3 Europe Infertility Drugs Sales, Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Infertility Drugs Sales, Revenue and Growth Rate (2013-2018)

4.5 South America Infertility Drugs Sales, Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Infertility Drugs Sales, Revenue and Growth Rate (2013-2018)

5 North America Infertility Drugs by Countries, Type, Application and Manufacturers

5.1 North America Infertility Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Infertility Drugs Sales by Countries (2013-2018)

5.1.2 North America Infertility Drugs Revenue by Countries (2013-2018)

5.1.3 United States Infertility Drugs Sales and Growth Rate (2013-2018)

5.1.4 Canada Infertility Drugs Sales and Growth Rate (2013-2018)

5.1.5 Mexico Infertility Drugs Sales and Growth Rate (2013-2018)

5.2 North America Infertility Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)

5.2.1 North America Infertility Drugs Sales by Manufacturers (2016-2017)

5.2.2 North America Infertility Drugs Revenue by Manufacturers (2016-2017)

5.3 North America Infertility Drugs Sales, Revenue and Market Share by Type (2013-2018)

5.3.1 North America Infertility Drugs Sales and Sales Share by Type (2013-2018)

5.3.2 North America Infertility Drugs Revenue and Revenue Share by Type (2013-2018)

5.4 North America Infertility Drugs Sales, Revenue and Market Share by Application (2013-2018)

5.4.1 North America Infertility Drugs Sales and Sales Share by Application (2013-2018)

5.4.2 North America Infertility Drugs Revenue and Revenue Share by Application (2013-2018)

6 Europe Infertility Drugs by Countries, Type, Application and Manufacturers

6.1 Europe Infertility Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Infertility Drugs Sales by Countries (2013-2018)

6.1.2 Europe Infertility Drugs Revenue by Countries (2013-2018)

6.1.3 Germany Infertility Drugs Sales and Growth Rate (2013-2018)

6.1.4 UK Infertility Drugs Sales and Growth Rate (2013-2018)

6.1.5 France Infertility Drugs Sales and Growth Rate (2013-2018)

6.1.6 Russia Infertility Drugs Sales and Growth Rate (2013-2018)

6.1.7 Italy Infertility Drugs Sales and Growth Rate (2013-2018)

6.2 Europe Infertility Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)

6.2.1 Europe Infertility Drugs Sales by Manufacturers (2016-2017)

6.2.2 Europe Infertility Drugs Revenue by Manufacturers (2016-2017)

6.3 Europe Infertility Drugs Sales, Revenue and Market Share by Type (2013-2018)

6.3.1 Europe Infertility Drugs Sales and Sales Share by Type (2013-2018)

6.3.2 Europe Infertility Drugs Revenue and Revenue Share by Type (2013-2018)

6.4 Europe Infertility Drugs Sales, Revenue and Market Share by Application (2013-2018)

6.4.1 Europe Infertility Drugs Sales and Sales Share by Application (2013-2018)

6.4.2 Europe Infertility Drugs Revenue and Revenue Share by Application (2013-2018)

7 Asia-Pacific Infertility Drugs by Countries, Type, Application and Manufacturers

7.1 Asia-Pacific Infertility Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Infertility Drugs Sales by Countries (2013-2018)

7.1.2 Asia-Pacific Infertility Drugs Revenue by Countries (2013-2018)

7.1.3 China Infertility Drugs Sales and Growth Rate (2013-2018)

7.1.4 Japan Infertility Drugs Sales and Growth Rate (2013-2018)

7.1.5 Korea Infertility Drugs Sales and Growth Rate (2013-2018)

7.1.6 India Infertility Drugs Sales and Growth Rate (2013-2018)

7.1.7 Southeast Asia Infertility Drugs Sales and Growth Rate (2013-2018)

7.2 Asia-Pacific Infertility Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)

7.2.1 Asia-Pacific Infertility Drugs Sales by Manufacturers (2016-2017)

7.2.2 Asia-Pacific Infertility Drugs Revenue by Manufacturers (2016-2017)

7.3 Asia-Pacific Infertility Drugs Sales, Revenue and Market Share by Type (2013-2018)

7.3.1 Asia-Pacific Infertility Drugs Sales and Sales Share by Type (2013-2018)

7.3.2 Asia-Pacific Infertility Drugs Revenue and Revenue Share by Type (2013-2018)

7.4 Asia-Pacific Infertility Drugs Sales, Revenue and Market Share by Application (2013-2018)

7.4.1 Asia-Pacific Infertility Drugs Sales and Sales Share by Application (2013-2018)

7.4.2 Asia-Pacific Infertility Drugs Revenue and Revenue Share by Application (2013-2018)

8 South America Infertility Drugs by Countries, Type, Application and Manufacturers

8.1 South America Infertility Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Infertility Drugs Sales by Countries (2013-2018)

8.1.2 South America Infertility Drugs Revenue by Countries (2013-2018)

8.1.3 Brazil Infertility Drugs Sales and Growth Rate (2013-2018)

8.1.4 Argentina Infertility Drugs Sales and Growth Rate (2013-2018)

8.1.5 Colombia Infertility Drugs Sales and Growth Rate (2013-2018)

8.2 South America Infertility Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)

8.2.1 South America Infertility Drugs Sales by Manufacturers (2016-2017)

8.2.2 South America Infertility Drugs Revenue by Manufacturers (2016-2017)

8.3 South America Infertility Drugs Sales, Revenue and Market Share by Type (2013-2018)

8.3.1 South America Infertility Drugs Sales and Sales Share by Type (2013-2018)

8.3.2 South America Infertility Drugs Revenue and Revenue Share by Type (2013-2018)

8.4 South America Infertility Drugs Sales, Revenue and Market Share by Application (2013-2018)

8.4.1 South America Infertility Drugs Sales and Sales Share by Application (2013-2018)

8.4.2 South America Infertility Drugs Revenue and Revenue Share by Application (2013-2018)

9 Middle East and Africa Infertility Drugs by Countries, Type, Application and Manufacturers

9.1 Middle East and Africa Infertility Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Infertility Drugs Sales by Countries (2013-2018)

9.1.2 Middle East and Africa Infertility Drugs Revenue by Countries (2013-2018)

9.1.3 Saudi Arabia Infertility Drugs Sales and Growth Rate (2013-2018)

9.1.4 UAE Infertility Drugs Sales and Growth Rate (2013-2018)

9.1.5 Egypt Infertility Drugs Sales and Growth Rate (2013-2018)

9.1.6 Nigeria Infertility Drugs Sales and Growth Rate (2013-2018)

9.1.7 South Africa Infertility Drugs Sales and Growth Rate (2013-2018)

9.2 Middle East and Africa Infertility Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)

9.2.1 Middle East and Africa Infertility Drugs Sales by Manufacturers (2016-2017)

9.2.2 Middle East and Africa Infertility Drugs Revenue by Manufacturers (2016-2017)

9.3 Middle East and Africa Infertility Drugs Sales, Revenue and Market Share by Type (2013-2018)

9.3.1 Middle East and Africa Infertility Drugs Sales and Sales Share by Type (2013-2018)

9.3.1 Middle East and Africa Infertility Drugs Revenue and Revenue Share by Type (2013-2018)

9.4 Middle East and Africa Infertility Drugs Sales, Revenue and Market Share by Application (2013-2018)

9.4.1 Middle East and Africa Infertility Drugs Sales and Sales Share by Application (2013-2018)

9.4.2 Middle East and Africa Infertility Drugs Revenue and Revenue Share by Application (2013-2018)

10 Global Infertility Drugs Market Segment by Type

10.1 Global Infertility Drugs Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Infertility Drugs Sales and Market Share by Type (2013-2018)

10.1.2 Global Infertility Drugs Revenue and Market Share by Type (2013-2018)

10.2 Clomid Sales Growth and Price

10.2.1 Global Clomid Sales Growth (2013-2018)

10.2.2 Global Clomid Price (2013-2018)

10.3 Femara or letrozole Sales Growth and Price

10.3.1 Global Femara or letrozole Sales Growth (2013-2018)

10.3.2 Global Femara or letrozole Price (2013-2018)

10.4 Injectable gonadotropins and injectable FSH hormone products Sales Growth and Price

10.4.1 Global Injectable gonadotropins and injectable FSH hormone products Sales Growth (2013-2018)

10.4.2 Global Injectable gonadotropins and injectable FSH hormone products Price (2013-2018)

10.5 The GnRH pump Sales Growth and Price

10.5.1 Global The GnRH pump Sales Growth (2013-2018)

10.5.2 Global The GnRH pump Price (2013-2018)

10.6 Bromocriptine Sales Growth and Price

10.6.1 Global Bromocriptine Sales Growth (2013-2018)

10.6.2 Global Bromocriptine Price (2013-2018)

11 Global Infertility Drugs Market Segment by Application

11.1 Global Infertility Drugs Sales Market Share by Application (2013-2018)

11.2 Male Sales Growth (2013-2018)

11.3 Female Sales Growth (2013-2018)

12 Infertility Drugs Market Forecast (2018-2023)

12.1 Global Infertility Drugs Sales, Revenue and Growth Rate (2018-2023)

12.2 Infertility Drugs Market Forecast by Regions (2018-2023)

12.2.1 North America Infertility Drugs Market Forecast (2018-2023)

12.2.2 Europe Infertility Drugs Market Forecast (2018-2023)

12.2.3 Asia-Pacific Infertility Drugs Market Forecast (2018-2023)

12.2.4 South America Infertility Drugs Market Forecast (2018-2023)

12.2.5 Middle East and Africa Infertility Drugs Market Forecast (2018-2023)

12.3 Infertility Drugs Market Forecast by Type (2018-2023)

12.3.1 Global Infertility Drugs Sales Forecast by Type (2018-2023)

12.3.2 Global Infertility Drugs Market Share Forecast by Type (2018-2023)

12.4 Infertility Drugs Market Forecast by Application (2018-2023)

12.4.1 Global Infertility Drugs Sales Forecast by Application (2018-2023)

12.4.2 Global Infertility Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Infertility Drugs Picture

Table Product Specifications of Infertility Drugs

Figure Global Infertility Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (US

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery